title: [Metabolic effects of static physical load under the conditions of pharmakologicheskoĭ mobilization of physical endurance].
abstract: The model of static physical loading (SPL) was used to study the biochemical effects of graded static tension and potentiality for pharmacological mobilization of physical endurance with participation of male volunteers. A close pathogenetic linkage between the established metabolic effects of the model and their adaptive adequacy to the stressing factor show that there is every reason to arrange the observed shifts in a SPL syndrome. The SPL syndrome is primarily manifested by exaggerated tone of the adrenoactive structures, inhibition of insulin production by the pancreas, activation of the neuropeptide anti-stress mechanisms, predominant utilization of the lipid substrate in energy production, intensification of protein catabolism, and increase in myocyte membrane permeability due to energy deficit. The investigation demonstrated that improvement of static physical endurance can be attained with a mobilizing stimulator (sidnocarb) and a combination of sidnocarb with a nonmediatory preparation (bemytil). This pharmacological combination levels side-effects of exorbitant activation of the adrenal system. On the contrary, a metabolic vitamin-microelements complex ("cocktail C") perceivably enhances SPL endurance (sidnocarb dose was lowered in three times), possesses the stress-protective effect, the ability to moderate the intensity of free (uninvolved in phosphorylation) oxidation and to optimize energy-plastic processes with predominant utilization of the lipid substrate.
authors.forename: S N
authors.initials: SN
authors.lastname: Nagornev
authors.forename: S V
authors.initials: SV
authors.lastname: Kalinkin
authors.forename: I P
authors.initials: IP
authors.lastname: Bobrovnitskiĭ
authors.forename: S I
authors.initials: SI
authors.lastname: Sytnik
authors.forename: T V
authors.initials: TV
authors.lastname: Petrova
authors.forename: T A
authors.initials: TA
authors.lastname: Orlova
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology* / Q000627:therapeutic use; D000328:Adult; D001205:Ascorbic Acid / Q000494:pharmacology* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000494:pharmacology* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004734:Energy Metabolism / Q000187:drug effects*; D006801:Humans; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D010743:Phospholipids / Q000378:metabolism; D010807:Physical Endurance / Q000187:drug effects*; D013315:Stress, Psychological / Q000517:prevention & control; D013558:Sydnones / Q000494:pharmacology* / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D001562:Benzimidazoles; D000697:Central Nervous System Stimulants; D010743:Phospholipids; D013558:Sydnones; D014803:Vitamin B Complex; C049825:bemethyl; D001205:Ascorbic Acid; C009257:sidnocarb